Jianyong Li

机构：Jiangsu Cancer Hospital, Nanjing Medical University · ORCID：0000-0002-9931-4055

发表论文 1073 篇 · 总被引 16279 次 · h-index 55

代表论文

• Clinical implications of ctDNA-based minimal residual disease detection in newly diagnosed peripheral T-cell lymphoma: a single-center cohort study (2025 · Cell Communication and Signaling · 被引 4)
• Nomogram for predicting the 30- and 90-day prognoses of hemophagocytic lymphohistiocytosis patients: a multicenter and retrospective study (2025 · Annals of Hematology · 被引 3)
• Endothelial Activation and Stress Index Serves as a Predictor for Survival in Lymphoma‐Associated Hemophagocytic Lymphohistiocytosis: A Retrospective Multicenter Cohort Study of Jiangsu Cooperative Lymphoma Group (2025 · American Journal of Hematology · 被引 3)
• Clinical characteristics and survival outcomes of thymic mucosa‐associated lymphoid tissue lymphoma: A multicenter analysis of 82 patients (2025 · Cancer · 被引 2)
• Phase 1/2 studies of DZD8586 in CLL/SLL patients after COVALENT and non-COVALENT BTK inhibitors and BTK degraders – extended follow-up report (2025 · Blood · 被引 2)
• CD180 as a Robust Immunophenotypic Marker for Differentiating Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia From Marginal Zone Lymphoma (2025 · Modern Pathology · 被引 2)